HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hui Ding Selected Research

Meningioma (Meningiomas)

12/2017Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion.
12/2016Overexpression of MAC30 is Resistant to Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer.
1/2016Prognostic Value of MAC30 Expression in Human Pure Squamous Cell Carcinomas of the Lung.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hui Ding Research Topics

Disease

85Neoplasms (Cancer)
01/2024 - 01/2006
14Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 01/2017
13Infections
01/2024 - 03/2011
13Breast Neoplasms (Breast Cancer)
02/2023 - 04/2010
12Inflammation (Inflammations)
01/2024 - 11/2015
10Neoplasm Metastasis (Metastasis)
03/2024 - 01/2014
10Hypoxia (Hypoxemia)
03/2024 - 01/2016
10Stomach Neoplasms (Stomach Cancer)
03/2022 - 04/2014
10Glioma (Gliomas)
11/2020 - 10/2007
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 10/2014
8Parkinson Disease (Parkinson's Disease)
11/2023 - 11/2009
8Alzheimer Disease (Alzheimer's Disease)
06/2023 - 09/2015
7Lung Neoplasms (Lung Cancer)
03/2024 - 04/2010
7Urinary Bladder Neoplasms (Bladder Cancer)
01/2024 - 11/2013
6Wounds and Injuries (Trauma)
12/2024 - 10/2016
6Hypersensitivity (Allergy)
11/2023 - 03/2011
6Glioblastoma (Glioblastoma Multiforme)
01/2022 - 05/2017
6Carcinogenesis
01/2022 - 10/2010
6Hepatocellular Carcinoma (Hepatoma)
01/2022 - 04/2012
6Carcinoma (Carcinomatosis)
01/2021 - 04/2010
6Traumatic Brain Injuries (Traumatic Brain Injury)
12/2017 - 06/2015
5Liver Neoplasms (Liver Cancer)
03/2024 - 01/2010
5Ovarian Epithelial Carcinoma
01/2022 - 10/2010
5Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 01/2016
5Brain Neoplasms (Brain Tumor)
01/2019 - 10/2007
5Pulmonary Fibrosis (Fibrosing Alveolitis)
12/2018 - 04/2010
5Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2014 - 04/2010
4Nevus of Ota
05/2024 - 12/2020
4Epilepsy (Aura)
04/2024 - 03/2013
4Edema (Dropsy)
01/2024 - 12/2018
4Prostatic Neoplasms (Prostate Cancer)
01/2024 - 01/2013
4Acute Lung Injury
01/2024 - 01/2014
4Fibrosis (Cirrhosis)
01/2023 - 03/2018
4Keratoconus
01/2022 - 03/2018
4Lung Injury
01/2020 - 01/2016
4Brain Injuries (Brain Injury)
05/2017 - 06/2015
3Ulcer
12/2024 - 01/2015
3Endometriosis
03/2024 - 09/2021
3Disease Progression
01/2024 - 01/2014
3COVID-19
01/2024 - 11/2021
3Coronary Artery Disease (Coronary Atherosclerosis)
12/2023 - 10/2019
3Pain (Aches)
11/2023 - 02/2012
3Rupture
06/2023 - 04/2020
3Pleural Effusion (Pleural Effusions)
01/2022 - 12/2017
3Leukemia
01/2019 - 12/2006

Drug/Important Bio-Agent (IBA)

34Proteins (Proteins, Gene)FDA Link
01/2024 - 10/2007
17Biomarkers (Surrogate Marker)IBA
01/2024 - 10/2010
12MicroRNAs (MicroRNA)IBA
01/2023 - 11/2013
11Messenger RNA (mRNA)IBA
11/2023 - 03/2009
10EnzymesIBA
03/2024 - 01/2009
10poly(malic acid)IBA
01/2019 - 10/2010
9Therapeutic UsesIBA
01/2024 - 01/2014
8AntioxidantsIBA
06/2023 - 08/2015
7Long Noncoding RNAIBA
03/2024 - 01/2019
7Peptides (Polypeptides)IBA
02/2023 - 03/2006
7malic acid (malate)IBA
01/2019 - 10/2007
7Antisense OligonucleotidesIBA
01/2017 - 10/2007
6LipopolysaccharidesIBA
01/2024 - 02/2007
6Monoclonal AntibodiesIBA
12/2023 - 10/2007
6LigandsIBA
11/2023 - 11/2006
6CytokinesIBA
05/2022 - 01/2011
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2022 - 11/2014
6Contrast MediaIBA
01/2020 - 03/2013
6NanoconjugatesIBA
01/2019 - 01/2010
5CurcuminIBA
11/2023 - 09/2015
5AntibodiesIBA
11/2022 - 10/2007
5Oxygen (Dioxygen)IBA
01/2019 - 01/2006
5CollagenIBA
12/2018 - 04/2010
4FlavonoidsIBA
06/2023 - 05/2017
4CateninsIBA
02/2023 - 10/2014
4EndostatinsIBA
01/2022 - 01/2016
4RNA (Ribonucleic Acid)IBA
01/2022 - 04/2011
4Interleukin-6 (Interleukin 6)IBA
09/2021 - 01/2016
4GoldIBA
01/2021 - 01/2016
4UbiquitinIBA
10/2018 - 01/2017
4Fluorouracil (Carac)FDA LinkGeneric
07/2015 - 12/2006
3Cisplatin (Platino)FDA LinkGeneric
11/2023 - 01/2017
3Toll-Like Receptor 4IBA
06/2023 - 02/2016
3Transcription Factors (Transcription Factor)IBA
06/2022 - 07/2011
3activin AIBA
01/2022 - 04/2017
3PlatinumIBA
01/2022 - 12/2016
3ErbB Receptors (EGF Receptor)IBA
01/2022 - 12/2013
3ORALIT (ORS)IBA
01/2021 - 01/2015
3Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 01/2017
3Sirtuin 1IBA
01/2021 - 01/2019
3Immunoconjugates (Immunoconjugate)IBA
11/2020 - 01/2019
3ImmunosorbentsIBA
10/2020 - 12/2017
3Reactive Oxygen Species (Oxygen Radicals)IBA
04/2019 - 02/2012
3PolymersIBA
01/2019 - 11/2010
3Proteasome Endopeptidase Complex (Proteasome)IBA
10/2018 - 01/2017

Therapy/Procedure

45Therapeutics
04/2024 - 10/2006
12Drug Therapy (Chemotherapy)
01/2024 - 01/2012
7Lasers (Laser)
04/2024 - 03/2018
7Immunotherapy
01/2023 - 09/2015
4Cystectomy
01/2024 - 01/2020
4Aftercare (After-Treatment)
05/2022 - 01/2018
4Hysterectomy
12/2015 - 04/2010
3Solid-State Lasers
05/2024 - 12/2020
3Electrodes (Electrode)
01/2020 - 03/2013
3Myotomy
03/2018 - 03/2016